350 related articles for article (PubMed ID: 1346640)
1. Neuromodulatory effects of atrial natriuretic peptides correlate with an inhibition of adenylate cyclase but not an activation of guanylate cyclase.
Drewett JG; Ziegler RJ; Trachte GJ
J Pharmacol Exp Ther; 1992 Feb; 260(2):689-96. PubMed ID: 1346640
[TBL] [Abstract][Full Text] [Related]
2. Neuromodulatory effects of atrial natriuretic factor are independent of guanylate cyclase in adrenergic neuronal pheochromocytoma cells.
Drewett JG; Ziegler RJ; Trachte GJ
J Pharmacol Exp Ther; 1990 Nov; 255(2):497-503. PubMed ID: 1978729
[TBL] [Abstract][Full Text] [Related]
3. Atrial natriuretic factor receptor heterogeneity and stimulation of particulate guanylate cyclase and cyclic GMP accumulation.
Leitman DC; Murad F
Endocrinol Metab Clin North Am; 1987 Mar; 16(1):79-105. PubMed ID: 2892671
[TBL] [Abstract][Full Text] [Related]
4. Neuromodulatory effect of the atrial natriuretic factor clearance receptor binding peptide, cANF(4-23)-NH2 in rabbit isolated vasa deferentia.
Johnson BG; Trachte GJ; Drewett JG
J Pharmacol Exp Ther; 1991 May; 257(2):720-6. PubMed ID: 1851836
[TBL] [Abstract][Full Text] [Related]
5. Cellular mechanisms of action of atrial natriuretic factor.
Gerzer R; Heim JM; Schütte B; Weil J
Klin Wochenschr; 1987; 65 Suppl 8():109-14. PubMed ID: 2885440
[TBL] [Abstract][Full Text] [Related]
6. Atrial natriuretic factor alters neurotransmission independently of guanylate cyclase-coupled receptors in the rabbit vas deferens.
Trachte GJ
J Pharmacol Exp Ther; 1993 Mar; 264(3):1227-33. PubMed ID: 8095549
[TBL] [Abstract][Full Text] [Related]
7. Atrial natriuretic factor reduces cyclic adenosine monophosphate content of human fibroblasts by enhancing phosphodiesterase activity.
Lee MA; West RE; Moss J
J Clin Invest; 1988 Aug; 82(2):388-93. PubMed ID: 2457032
[TBL] [Abstract][Full Text] [Related]
8. Ring-deleted analogs of atrial natriuretic factor inhibit adenylate cyclase/cAMP system. Possible coupling of clearance atrial natriuretic factor receptors to adenylate cyclase/cAMP signal transduction system.
Anand-Srivastava MB; Sairam MR; Cantin M
J Biol Chem; 1990 May; 265(15):8566-72. PubMed ID: 2160462
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of action of atrial natriuretic factor: clinical consequences.
Gerzer R; Weil J; Strom T; Müller T
Klin Wochenschr; 1986; 64 Suppl 6():21-6. PubMed ID: 2879064
[TBL] [Abstract][Full Text] [Related]
10. Cyclic guanosine 3',5' monophosphate mediates the inhibitory effect of atrial natriuretic factor in adrenergic, neuronal pheochromocytoma cells.
Drewett JG; Ziegler RJ; Marchand GR; Trachte GJ
J Pharmacol Exp Ther; 1989 Aug; 250(2):428-32. PubMed ID: 2547929
[TBL] [Abstract][Full Text] [Related]
11. Signaling pathways involved in atrial natriuretic factor and dopamine regulation of renal Na+, K+ -ATPase activity.
Correa AH; Choi MR; Gironacci M; Valera MS; Fernández BE
Regul Pept; 2007 Jan; 138(1):26-31. PubMed ID: 17005263
[TBL] [Abstract][Full Text] [Related]
12. Atrial natriuretic peptide-C receptor-induced attenuation of adenylyl cyclase signaling activates phosphatidylinositol turnover in A10 vascular smooth muscle cells.
Mouawad R; Li Y; Anand-Srivastava MB
Mol Pharmacol; 2004 Apr; 65(4):917-24. PubMed ID: 15044621
[TBL] [Abstract][Full Text] [Related]
13. Somatostatin inhibits interleukin 6 release from rat cortical type I astrocytes via the inhibition of adenylyl cyclase.
Grimaldi M; Florio T; Schettini G
Biochem Biophys Res Commun; 1997 Jun; 235(1):242-8. PubMed ID: 9196070
[TBL] [Abstract][Full Text] [Related]
14. Effect of cyclic GMP-increasing agents nitric oxide and C-type natriuretic peptide on bovine chromaffin cell function: inhibitory role mediated by cyclic GMP-dependent protein kinase.
Rodriguez-Pascual F; Miras-Portugal MT; Torres M
Mol Pharmacol; 1996 Jun; 49(6):1058-70. PubMed ID: 8649344
[TBL] [Abstract][Full Text] [Related]
15. The role of cyclic nucleotides in atrial natriuretic peptide-mediated inhibition of aldosterone secretion.
Barrett PQ; Isales CM
Endocrinology; 1988 Mar; 122(3):799-808. PubMed ID: 2830096
[TBL] [Abstract][Full Text] [Related]
16. Differential antimitogenic effectiveness of atrial natriuretic peptides in primary versus subcultured rat aortic smooth muscle cells: relationship to expression of ANF-C receptors.
Cahill PA; Hassid A
J Cell Physiol; 1993 Jan; 154(1):28-38. PubMed ID: 7678266
[TBL] [Abstract][Full Text] [Related]
17. Quercetin, a phytoestrogen and dietary flavonoid, activates different membrane-bound guanylate cyclase isoforms in LLC-PK1 and PC12 cells.
Chen ZJ; Vetter M; Chang GD; Liu S; Chang CH
J Pharm Pharmacol; 2003 Mar; 55(3):353-8. PubMed ID: 12724041
[TBL] [Abstract][Full Text] [Related]
18. The presence of atrial-natriuretic-factor receptors of ANF-R2 subtype in rat platelets. Coupling to adenylate cyclase/cyclic AMP signal-transduction system.
Anand-Srivastava MB; Gutkowska J; Cantin M
Biochem J; 1991 Aug; 278 ( Pt 1)(Pt 1):211-7. PubMed ID: 1652938
[TBL] [Abstract][Full Text] [Related]
19. Cyclic GMP as mediator and biological marker of atrial natriuretic factor.
Hamet P; Tremblay J; Pang SC; Skuherska R; Schiffrin EL; Garcia R; Cantin M; Genest J; Palmour R; Ervin FR
J Hypertens Suppl; 1986 Jun; 4(2):S49-56. PubMed ID: 2873213
[TBL] [Abstract][Full Text] [Related]
20. The receptor attributable to C-type natriuretic peptide-induced differentiation of osteoblasts is switched from type B- to type C-natriuretic peptide receptor with aging.
Kaneki H; Kurokawa M; Ide H
J Cell Biochem; 2008 Feb; 103(3):753-64. PubMed ID: 17562543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
